Personalis Assets & Liabilities Overview 2018-2023 | PSNL
Personalis assets & liabilities overview from 2018 to 2023. Assets & liabilities overview can be defined as overview of the balance sheet showing the primary categories of assets, liabilities and equity in a single chart.
| Personalis Annual Assets & Liabilities Overview (Millions of US $) |
|---|
| Personalis Quarterly Assets & Liabilities Overview (Millions of US $) |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.064B | $0.073B |
| Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $15.482B | 5.59 |
| Dr Reddy's Laboratories (RDY) | India | $12.441B | 19.67 |
| Aspen Pharmacare (APNHY) | South Africa | $5.038B | 0.00 |
| BridgeBio Pharma (BBIO) | United States | $4.656B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.183B | 2.48 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.009B | 13.75 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.646B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.447B | 0.00 |
| Generation Bio (GBIO) | United States | $0.193B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.069B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.027B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.025B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |